Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8058 for Dry Eye Disease with MGD
NCT05515471Phase 3Completed
- Sponsor
- Hengrui
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 3 trial of perfluorohexyloctane in dry eye disease (DED), sponsored by Hengrui. Started Feb 2021; status: completed.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05515471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515471.